Reuters: Money News: Ranbaxy falls over 30 pct after FDA import alert

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Refresh your vocabulary. Learn a new word everyday by subscribing to Word of the Day. A great tool if you're studying for the GRE, GMAT or LSAT, or simply want to enhance your lexicon. From our sponsors

Ranbaxy falls over 30 pct after FDA import alert Sep 16th 2013, 03:58 MUMBAI (Reuters) - Shares in Ranbaxy Laboratories Ltd dropped more than 30 percent on Monday, after the U.S. Food and Drug Administration issued an import alert against company's Mohali plant.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions